Nursing 220 topic any age group relatd to oncology hematology immunology acute neurology emergency or critcal care nursing

ach utilizing the evidence from current nursing research literature so the best nursing practice in this specific area of oncologic nursing practice is established.Review of Literature: Stanley in her note, Partners in Cancer Care published from Oncology Nursing Society has highlighted the importance and availability of best evidence for managing common cancer symptoms. Evidence in support of nursing practice in this area is known to be accumulating exponentially, which demands utilization of these evidences in the clinical practice. Literature consistently demonstrates identifiable evidence base for oncology nursing and the impacts of these evidence-based interventions in patient outcomes as far as the oncology nursing practice is concerned. It is also important to evaluate the effectiveness of these interventions used for cancer symptom management, so recommendations for future practice can be made to result in improvement in patient care that can be measured. (Stanley, KJ., 2006).Nausea and vomiting continues to be significant side effects of cancer therapy that add to the distress of the patients. Optimal antiemetic prophylaxis in cancer patients receiving chemo and radiotherapies has been the subject of many trials. The Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) in their review presents the findings up to the year 2004. Classically, the chemotherapeutic agents have been classified with high, moderate, low, and minimal emetogenic potentials. The current recommendations support a three-drug regimen that includes a 5-HT3 antagonist such as ondansetron 32 mg, dexamethasone 12 mg, and aprepitant 125 mg on day 1, followed by dexamethasone 8 mg daily on days 2 to 4, and aprepitant 80 mg on days 2 to 3 provides a complete response of no emesis with no use of rescue antiemetic in prevention of vomiting and nausea induced by chemotherapy of high emetogenic risk. Likewise, there are recommendations for moderate